Contact

All Stories

  1. A pilot study of intensive short‐time continuous renal replacement therapy to substitute maintenance hemodialysis during transitional period of COVID‐19

    Article • Therapeutic Apheresis and Dialysis, November 2023, Wiley

    Dr. Cheng Xue

  2. Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels

    Article • BMC Nephrology, September 2023, Springer Science + Business Media

    Dr. Cheng Xue

  3. Potential factors associated with a long-term duration of B-cell depletion after using rituximab in patients with nephrotic syndrome

    Article • Pediatric Nephrology, September 2023, Springer Science + Business Media

    Dr. Cheng Xue

  4. Misdiagnosis of renal pelvic unicentric Castleman disease: a case report

    Article • Frontiers in Surgery, August 2023, Frontiers

    Dr. Cheng Xue

  5. Specific Nutritional Strategy Is Needed for Good Nutritional Status in Autosomal Dominant Polycystic Kidney Disease

    Article • Journal of Renal Nutrition, July 2023, Elsevier

    Dr. Cheng Xue

  6. Influence of SGLT2i and RAASi and Their Combination on Risk of Hyperkalemia in DKD

    Article • Clinical Journal of the American Society of Nephrology, May 2023, Wolters Kluwer Health

    Dr. Cheng Xue

  7. Golden mean of serum uric acid level on the risk of kidney function decline

    Article • Clinical and Experimental Nephrology, March 2023, Springer Science + Business Media

    Dr. Cheng Xue

  8. Vascular calcification on the risk of kidney stone: a meta-analysis

    Article • Renal Failure, March 2023, Taylor & Francis

    Dr. Cheng Xue

  9. Automatic Segmentation of Kidney Volume Using Multi-Module Hybrid Based U-Shape in Polycystic Kidney Disease

    Article • IEEE Access, January 2023, Institute of Electrical & Electronics Engineers (IEEE)

    Dr. Cheng Xue

  10. Urine biomarkers can outperform serum biomarkers in certain diseases

    Article • URINE, January 2023, Elsevier

    Dr. Cheng Xue

  11. A Nomogram to Identify Hyperkalemia Risk in Patients with Advanced CKD

    Article • Kidney360, October 2022, Wolters Kluwer Health

    Dr. Cheng Xue

  12. p-Cresyl sulfate predicts clinical outcomes in sustained peritoneal dialysis: a 5-year follow-up cohort study and meta-analysis

    Article • Renal Failure, October 2022, Taylor & Francis

    Dr. Cheng Xue

  13. Susceptibility of renal fibrosis in diabetes: Role of hypoxia inducible factor‐1

    Article • The FASEB Journal, July 2022, Wiley

    Dr. Cheng Xue

  14. Anoctamin 1 Inhibition Suppresses Cystogenesis by Enhancing Ciliogenesis and the Ciliary Dosage of Polycystins

    Article • Frontiers in Bioscience-Landmark, July 2022, IMR Press

    Dr. Cheng Xue

  15. Chromatin Methylation Abnormalities in Autosomal Dominant Polycystic Kidney Disease

    Article • Frontiers in Medicine, July 2022, Frontiers

    Dr. Cheng Xue

  16. In-center Nocturnal Hemodialysis Reduced the Circulating FGF23, Left Ventricular Hypertrophy, and All-Cause Mortality: A Retrospective Cohort Study

    Article • Frontiers in Medicine, June 2022, Frontiers

    Dr. Cheng Xue

  17. Late venous laceration after inappropriate placement of a left internal jugular hemodialysis catheter: a case report

    Article • Journal of International Medical Research, April 2022, SAGE Publications

    Dr. Cheng Xue

  18. A program for early detection and management of chronic kidney disease

    Article • Renal Failure, February 2022, Taylor & Francis

    Dr. Cheng Xue

  19. Prognostic analysis of crescentic glomerulonephritis with acute kidney injury: a single-center cohort with 5-year follow-up

    Article • International Urology and Nephrology, February 2022, Springer Science + Business Media

    Dr. Cheng Xue

  20. Comparison of Outcomes between Percutaneous and Surgical Placement of Peritoneal Dialysis Catheters in Uremic Patients: A Meta-Analysis

    Article • Blood Purification, September 2021, Karger Publishers

    Dr. Cheng Xue

  21. Fibroblast Growth Factor 23 Is a Valuable Predictor of Autosomal Dominant Polycystic Kidney Disease Progression

    Article • Kidney International Reports, May 2021, Elsevier

    Dr. Cheng Xue

  22. The Role of Renal Pathology in the Prognosis and Recovery of Community-Acquired Acute Kidney Injury

    Article • January 2021, Karger Publishers

    Dr. Cheng Xue

  23. Inflammatory cytokine depletion in severe coronavirus disease 2019 infectious pneumonia

    Article • Medicine, December 2020, Wolters Kluwer Health

    Dr. Cheng Xue

  24. Coronavirus-associated kidney outcomes in COVID-19, SARS, and MERS: a meta-analysis and systematic review

    Article • Renal Failure, November 2020, Taylor & Francis

    Professor Albert Ong, Dr. Cheng Xue

  25. Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis

    Article • Clinical Kidney Journal, November 2020, Oxford University Press (OUP)

    Dr. Cheng Xue

  26. Inflammatory cytokines depletion for severe COVID-19 infectious pneumonia: a case report

    Article • June 2020, Research Square

    Dr. Cheng Xue

  27. The fertility willingness and acceptability of preimplantation genetic testing in Chinese patients with autosomal dominant polycystic kidney disease

    Article • BMC Nephrology, April 2020, Springer Science + Business Media

    Dr. Cheng Xue

  28. Executive Summary: Clinical Practice Guideline for Autosomal Dominant Polycystic Kidney Disease in China

    Article • Kidney Diseases, January 2020, Karger Publishers

    Cheng Xue, Dr. Cheng Xue

  29. Effect of Statins on Renal Function and Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease

    Article • Kidney Diseases, January 2020, Karger Publishers

    Dr. Cheng Xue

  30. COVID-19 Infection in a Patient with End-Stage Kidney Disease

    Article • January 2020, Karger Publishers

    Dr. Cheng Xue

  31. Nocturnal Hemodialysis Compared with Conventional Dialysis for End-Stage Renal Disease Treatment in Polycystic Kidney Disease Patients

    Article • Blood Purification, November 2019, Karger Publishers

    Dr. Cheng Xue

  32. Treatment Options for Kidney Failure in China: Conservative Management More Than Dialysis?

    Article • Kidney Medicine, November 2019, Elsevier

    Dr. Cheng Xue

  33. New-onset glucose disorders in peritoneal dialysis patients: a meta-analysis and systematic review

    Article • Nephrology Dialysis Transplantation, June 2019, Oxford University Press (OUP)

    Dr. Cheng Xue

  34. Timing of Renal-Replacement Therapy in Acute Kidney Injury and Sepsis

    Article • New England Journal of Medicine, January 2019, New England Journal of Medicine (NEJM/MMS)

    Dr. Cheng Xue

  35. Is urinary oxalate inversely correlated with glomerular filtration rate in chronic kidney disease?

    Article • Renal Failure, January 2019, Taylor & Francis

    Dr. Cheng Xue

  36. Identification of Key Genes and Candidated Pathways in Human Autosomal Dominant Polycystic Kidney Disease by Bioinformatics Analysis

    Article • Kidney and Blood Pressure Research, January 2019, Karger Publishers

    Dr. Cheng Xue

  37. Clinical Characteristics and Outcomes of Community-Acquired versus Hospital-Acquired Acute Kidney Injury: A Meta-Analysis

    Article • Kidney and Blood Pressure Research, January 2019, Karger Publishers

    Dr. Cheng Xue

  38. Comparisons of Cardiotoxicity and Efficacy of Anthracycline-Based Therapies in Breast Cancer: A Network Meta-Analysis of Randomized Clinical Trials

    Article • Oncology Research and Treatment, January 2019, Karger Publishers

    Dr. Cheng Xue

  39. Polycystic Kidney Disease and Renal Fibrosis

    Article • January 2019, Springer Science + Business Media

    Dr. Cheng Xue

  40. Changing procedures for resolving medical disputes in China

    Article • Internal Medicine Journal, December 2018, Wiley

    Dr. Cheng Xue

  41. Preimplantation Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease Applied in China

    Article • American Journal of Kidney Diseases, November 2018, Elsevier

    Dr. Cheng Xue

  42. Fibroblast Growth Factor-23 May Follow Cardiovascular Disease Rather than Causing It in Chronic Kidney Disease

    Article • Journal of the American Society of Nephrology, August 2018, American Society of Nephrology

    Cheng Xue, Dr. Cheng Xue

  43. Dialysis modality and mortality in polycystic kidney disease

    Article • Hemodialysis International, May 2018, Wiley

    Dr. Cheng Xue

  44. Saikosaponin-d inhibits proliferation by up-regulating autophagy via the CaMKKβ–AMPK–mTOR pathway in ADPKD cells

    Article • Molecular and Cellular Biochemistry, April 2018, Springer Science + Business Media

    Dr. Cheng Xue

  45. Total kidney volume: the most valuable predictor of autosomal dominant polycystic kidney disease progression

    Article • Kidney International, March 2018, Elsevier

    Dr. Cheng Xue

  46. Comment to: Differences in characteristics and outcomes between community- and hospital-acquired acute kidney injury: A systematic review and meta-analysis. Clinical Nephrology, 2017; 88: 167-182

    Article • Clinical Nephrology, November 2017, Dustri-Verlgag Dr. Karl Feistle

    Dr. Cheng Xue

  47. Amputation of the first metatarsophalangeal joint due to a giant gouty tophi

    Article • Medicine, October 2017, Wolters Kluwer Health

    Dr. Cheng Xue

  48. Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial

    Article • BMJ Open, February 2017, BMJ

    Dr. Cheng Xue

  49. Fibroblast Growth Factor 23 Predicts All-Cause Mortality in a Dose-Response Fashion in Pre-Dialysis Patients with Chronic Kidney Disease

    Article • American Journal of Nephrology, December 2016, Karger Publishers

    Dr. Cheng Xue

  50. The Clinical Manifestation and Management of Autosomal Dominant Polycystic Kidney Disease in China

    Article • Kidney Diseases, January 2016, Karger Publishers

    Dr. Cheng Xue

  51. Antihypertensive treatments in adult autosomal dominant polycystic kidney disease: network meta-analysis of the randomized controlled trials

    Article • Oncotarget, December 2015, Impact Journals, LLC

    Dr. Cheng Xue

  52. Relationship of pre-operative serum brain natriuretic peptide with risk of acute kidney injury after cardiac surgery

    Article • Academic Journal of Second Military Medical University, January 2015, China Science Publishing & Media Ltd.

    Dr. Cheng Xue

  53. Effects ofendothelial nitric oxide synthasegene on end stage renal disease progression in autosomal dominant polycystic kidney disease

    Article • Nephrology, September 2014, Wiley

    Dr. Cheng Xue

  54. 4 G/4 G polymorphism ofplasminogen activator inhibitor-1 geneincreases the risk of diabetic nephropathy

    Article • Renal Failure, December 2013, Taylor & Francis

    Dr. Cheng Xue

  55. Apolipoprotein E Gene Variants on the Risk of End Stage Renal Disease

    Article • PLoS ONE, December 2013, PLOS

    Dr. Cheng Xue

  56. C509T and T869C polymorphisms of transforming growth factor β1 and the risk of IgA nephropathy: a meta-analysis

    Article • Chinese Medical Journal, December 2013, Wolters Kluwer Health

    Dr. Cheng Xue

  57. Chronic kidney disease-mineral and bone disorder and energy metabolism

    Article • Academic Journal of Second Military Medical University, November 2013, China Science Publishing & Media Ltd.

    Dr. Cheng Xue

  58. Secretoglobin 1A member 1 (SCGB1A1) +38A/G polymorphism is associated with asthma risk: A meta-analysis

    Article • Gene, October 2013, Elsevier

    Dr. Cheng Xue

  59. Long-Term Treatment with Mammalian Target of Rapamycin Inhibitor Does Not Benefit Patients with Autosomal Dominant Polycystic Kidney Disease: A Meta-Analysis

    Article • Nephron Clinical Practice, January 2013, Karger Publishers

    Dr. Cheng Xue

  60. Histone deacetylases and autosomal dominant polycystic kidney disease

    Article • Academic Journal of Second Military Medical University, October 2011, China Science Publishing & Media Ltd.

    Dr. Cheng Xue